Impact of serogroup A meningococcal conjugate vaccine for Africa.

about

Impact of serogroup A meningococcal conjugate vaccine for Africa.

Item

http://www.wikidata.org/entity/Q46901358

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Impact of serogroup A meningococcal conjugate vaccine for Africa.

@en

Impact of serogroup A meningococcal conjugate vaccine for Africa.

@nl

type

Item

label

Impact of serogroup A meningococcal conjugate vaccine for Africa.

@en

Impact of serogroup A meningococcal conjugate vaccine for Africa.

@nl

prefLabel

Impact of serogroup A meningococcal conjugate vaccine for Africa.

@en

Impact of serogroup A meningococcal conjugate vaccine for Africa.

@nl

P1476

Impact of serogroup A meningococcal conjugate vaccine for Africa.

@en

P2093

James M Stuart

http://www.w3.org/2001/XMLSchema#string

P2860

Communication Challenges During the Development and Introduction of a New Meningococcal Vaccine in Africa

Introduction and Rollout of a New Group A Meningococcal Conjugate Vaccine (PsA-TT) in African Meningitis Belt Countries, 2010-2014

Regulatory Pathways That Facilitated Timely Registration of a New Group A Meningococcal Conjugate Vaccine for Africa's Meningitis Belt Countries

Technical Development of a New Meningococcal Conjugate Vaccine

The Evolution of the Meningitis Vaccine Project

From Epidemic Meningitis Vaccines for Africa to the Meningitis Vaccine Project

Effect of a serogroup A meningococcal conjugate vaccine (PsA-TT) on serogroup A meningococcal meningitis and carriage in Chad: a community study [corrected].

Emergence of epidemic Neisseria meningitidis serogroup C in Niger, 2015: an analysis of national surveillance data.

Serogroup A meningococcal conjugate vaccination in Burkina Faso: analysis of national surveillance data.

Persistent low carriage of serogroup A Neisseria meningitidis two years after mass vaccination with the meningococcal conjugate vaccine, MenAfriVac.

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/21645515.2017.1412022

http://www.w3.org/2001/XMLSchema#string

P577

2017-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29194010

http://www.w3.org/2001/XMLSchema#string

P932

5989890

http://www.w3.org/2001/XMLSchema#string